Waldemar Priebe

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Fokt Izabela; Szymanski Slawomir; Skora Stanislaw; Cybulski Marcin; Madden Timothy; Priebe Waldemar
D-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses.
Kong Ling-Yuan; Wei Jun; Sharma Amit K; Barr Jason; Abou-Ghazal Mohamed K; Fokt Izabela; Weinberg Jeffrey; Rao Ganesh; Grimm Elizabeth; Priebe Waldemar; Heimberger Amy B
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Heimberger Amy B; Priebe Waldemar
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Waldemar Priebe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Fokt Izabela; Szymanski Slawomir; Skora Stanislaw; Cybulski Marcin; Madden Timothy; Priebe Waldemar
D-glucose- and D-mannose-based antimetabolites. Part 2. Facile synthesis of 2-deoxy-2-halo-D-glucoses and -D-mannoses.
Carbohydrate research 2009;344(12):1464-73.
2009: Kong Ling-Yuan; Wei Jun; Sharma Amit K; Barr Jason; Abou-Ghazal Mohamed K; Fokt Izabela; Weinberg Jeffrey; Rao Ganesh; Grimm Elizabeth; Priebe Waldemar; Heimberger Amy B
A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Cancer immunology, immunotherapy : CII 2009;58(7):1023-32.
2008: Heimberger Amy B; Priebe Waldemar
Small molecular inhibitors of p-STAT3: novel agents for treatment of primary and metastatic CNS cancers.
Recent patents on CNS drug discovery 2008;3(3):179-88.
2008: Kong Ling-Yuan; Abou-Ghazal Mohamed K; Wei Jun; Chakraborty Arup; Sun Wei; Qiao Wei; Fuller Gregory N; Fokt Izabela; Grimm Elizabeth A; Schmittling Robert J; Archer Gary E; Sampson John H; Priebe Waldemar; Heimberger Amy B
A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5759-68.
2008: Corvis Yohann; Korchowiec Beata; Korchowiec Jacek; Badis Mounia; Mironiuk-Puchalska Ewa; Fokt Izabela; Priebe Waldemar; Rogalska Ewa
Complexation of metal ions in Langmuir films formed with two amphiphilic dioxadithia crown ethers.
The journal of physical chemistry. B 2008;112(35):10953-63.
2008: Verstovsek Srdan; Manshouri Taghi; Quintás-Cardama Alfonso; Harris David; Cortes Jorge; Giles Francis J; Kantarjian Hagop; Priebe Waldemar; Estrov Zeev
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):788-96.
2007: Ferrajoli Alessandra; Faderl Stefan; Van Quin; Koch Patricia; Harris David; Liu Zhiming; Hazan-Halevy Inbal; Wang Yongtao; Kantarjian Hagop M; Priebe Waldemar; Estrov Zeev
WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
Cancer research 2007;67(23):11291-9.
2007: Hussain S Farzana; Kong Ling-Yuan; Jordan Justin; Conrad Charles; Madden Timothy; Fokt Isabella; Priebe Waldemar; Heimberger Amy B
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Cancer research 2007;67(20):9630-6.
2007: Zheng Mingzhong; Priebe Waldemar; Walch Eugene T; Roth Katherine G; Han Mikyung; Tang Chi-Hui; Lee Sangkyou; Poindexter Nancy J; Fokt Izabela; Grimm Elizabeth A
WP760, a melanoma selective drug.
Cancer chemotherapy and pharmacology 2007;60(5):625-33.
2007: Bidwell Gene L; Davis Aisha N; Fokt Izabela; Priebe Waldemar; Raucher Drazen
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance.
Investigational new drugs 2007;25(4):313-26.
2007: Gruber Beata M; Anuszewska Elzbieta L; Bubko Irena; Gozdzik Aneta; Fokt Izabela; Priebe Waldemar
Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
Archivum immunologiae et therapiae experimentalis 2007;55(3):193-8.
2007: Mansilla Sylvia; Rojas Marta; Bataller Marc; Priebe Waldemar; Portugal José
Circumvention of the multidrug-resistance protein (MRP-1) by an antitumor drug through specific inhibition of gene transcription in breast tumor cells.
Biochemical pharmacology 2007;73(7):934-42.
2007: Bartholomeusz Geoffrey A; Talpaz Moshe; Kapuria Vaibhav; Kong Ling Yuan; Wang Shimei; Estrov Zeev; Priebe Waldemar; Wu Ji; Donato Nicholas J
Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells.
Blood 2007;109(8):3470-8.
2007: Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Oncogene 2007;26(17):2435-44.
2007: Bidwell Gene L; Fokt Izabela; Priebe Waldemar; Raucher Drazen
Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Biochemical pharmacology 2007;73(5):620-31.
2007: Tabe Yoko; Jin Linhua; Tsutsumi-Ishii Yuko; Xu Yuanyuan; McQueen Teresa; Priebe Waldemar; Mills Gordon B; Ohsaka Akimichi; Nagaoka Isao; Andreeff Michael; Konopleva Marina
Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.
Cancer research 2007;67(2):684-94.
2006: Lampidis Theodore J; Kurtoglu Metin; Maher Johnathan C; Liu Huaping; Krishan Awtar; Sheft Valerie; Szymanski Slawomir; Fokt Izabela; Rudnicki Witold R; Ginalski Krzysztof; Lesyng Bogdan; Priebe Waldemar
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Cancer chemotherapy and pharmacology 2006;58(6):725-34.
2006: Anuszewska Elzbieta; Chlopkiewicz Bozena; Gruber Beata; Marczewska Jadwiga; Priebe Waldemar; Skurzak Henryk
Estimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages.
Acta poloniae pharmaceutica 2006;63(4):321-4.
2006: Mansilla Sylvia; Priebe Waldemar; Portugal José
Transcriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53.
European journal of pharmacology 2006;540(1-3):34-45.
2006: Gruber Beata M; Anuszewska Elzbieta L; Roman Iza; Gozdzik Aneta; Priebe Waldemar; Fokt Izabela
Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.
Acta poloniae pharmaceutica 2006;63(1):15-8.
2006: Mansilla Sylvia; Priebe Waldemar; Portugal José
Mitotic catastrophe results in cell death by caspase-dependent and caspase-independent mechanisms.
Cell cycle (Georgetown, Tex.) 2006;5(1):53-60.
2005: Portugal José; Cashman Derek J; Trent John O; Ferrer-Miralles Neus; Przewloka Teresa; Fokt Izabela; Priebe Waldemar; Chaires Jonathan B
A new bisintercalating anthracycline with picomolar DNA binding affinity.
Journal of medicinal chemistry 2005;48(26):8209-19.
2005: Gruber Beata M; Anuszewska Elzbieta L; Bubko Irena; Gozdzik Aneta; Priebe Waldemar; Fokt Izabela
Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
Anticancer research 2005;25(3B):2193-8.
2005: Faderl Stefan; Ferrajoli Alessandra; Harris David; Van Quin; Priebe Waldemar; Estrov Zeev
WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
Anticancer research 2005;25(3B):1841-50.
2005: Chlopkiewicz Bozena; Ejchart Anna; Marczewska Jadwiga; Anuszewska Elzbieta; Priebe Waldemar
Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines.
Acta poloniae pharmaceutica 2005;62(2):99-104.
2005: Maher Johnathan C; Savaraj Niramol; Priebe Waldemar; Liu Huaping; Lampidis Theodore J
Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Pancreas 2005;30(2):e34-9.
2005: Gruber Beata M; Anuszewska Elzbieta L; Bubko Irena; Kasprzycka-Guttman Teresa; Misiewicz Irena; Skupinska Katarzyna; Priebe Waldemar; Fokt Izabela
Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines.
Acta poloniae pharmaceutica 2005;62(1):17-23.
2005: Nair Rajesh R; Wang Heng; Jamaluddin M S; Fokt Izabella; Priebe Waldemar; Boyd Douglas D
A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region.
Oncology research 2005;15(5):265-79.
2004: Marczewska Jadwiga; Anuszewska Elzbieta L; Priebe Waldemar
The application of the sister chromatid exchange test for evaluation of the novel anthracycline derivatives. Part I.
Acta poloniae pharmaceutica 2004;61 Suppl():22-4.
2004: Trevino Alex V; Woynarowska Barbara A; Herman Terence S; Priebe Waldemar; Woynarowski Jan M
Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues.
Molecular cancer therapeutics 2004;3(11):1403-10.
2004: Fox Keith R; Webster Richard; Phelps Robin J; Fokt Izabela; Priebe Waldemar
Sequence selective binding of bis-daunorubicin WP631 to DNA.
European journal of biochemistry / FEBS 2004;271(17):3556-66.
2004: Mansilla Sylvia; Priebe Waldemar; Portugal José
Sp1-targeted inhibition of gene transcription by WP631 in transfected lymphocytes.
Biochemistry 2004;43(23):7584-92.
2004: Maschek Gregory; Savaraj Niramol; Priebe Waldemar; Braunschweiger Paul; Hamilton Kara; Tidmarsh George F; De Young Linda R; Lampidis Theodore J
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Cancer research 2004;64(1):31-4.
2004: Ashikawa Kazuhiro; Shishodia Shishir; Fokt Izabel; Priebe Waldemar; Aggarwal Bharat B
Evidence that activation of nuclear factor-kappaB is essential for the cytotoxic effects of doxorubicin and its analogues.
Biochemical pharmacology 2004;67(2):353-64.
2004: Gruber Beata M; Anuszewska Elzbieta L; Priebe Waldemar
The effect of new anthracycline derivatives on the induction of apoptotic processes in human neoplastic cells.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2004;42(2):127-30.
2003: Fuks Leon; Samochocka Krystyna; Anulewicz-Ostrowska Romana; Kruszewski Marcin; Priebe Waldemar; Lewandowski Wlodzimierz
Structure and biological activity of cationic [PtLCl(DMSO)]NO(3).DMSO complex containing a chelated diaminosugar: methyl-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxopyranoside.
European journal of medicinal chemistry 2003;38(7-8):775-80.
2003: Haj Hayet Tayeb-Bel; Salerno Milena; Priebe Waldemar; Kozlowski Henryk; Garnier-Suillerot Arlette
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.
Chemico-biological interactions 2003;145(3):349-58.
2003: Villamarín Silvia; Mansilla Sylvia; Ferrer-Miralles Neus; Priebe Waldemar; Portugal José
A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.
European journal of biochemistry / FEBS 2003;270(4):764-70.
2003: Kruszewski Marcin; Bouzyk Elzbieta; Oldak Tomasz; Samochocka Krystyna; Fuks Leon; Lewandowski Wlodzimierz; Fokt Izabela; Priebe Waldemar
Differential toxic effect of cis-platinum(II) and palladium(II) chlorides complexed with methyl 3,4-diamine-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside in mouse lymphoma cell lines differing in DSB and NER repair ability.
Teratogenesis, carcinogenesis, and mutagenesis 2003;Suppl 1():1-11.
2002: Liu Huaping; Savaraj Niramol; Priebe Waldemar; Lampidis Theodore J
Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C).
Biochemical pharmacology 2002;64(12):1745-51.
2002: Booser Daniel J; Esteva Francisco J; Rivera Edgardo; Valero Vicente; Esparza-Guerra Laura; Priebe Waldemar; Hortobagyi Gabriel N
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.
Cancer chemotherapy and pharmacology 2002;50(1):6-8.
2002: Salerno Milena; Przewloka Teresa; Fokt Izabela; Priebe Waldemar; Garnier-Suillerot Arlette
Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.
Biochemical pharmacology 2002;63(8):1471-9.
2002: Villamarín Silvia; Ferrer-Miralles Neus; Mansilla Sylvia; Priebe Waldemar; Portugal José
Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes.
Biochemical pharmacology 2002;63(7):1251-8.
2001: Faderl S; Estrov Z; Kantarjian H M; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski J M; Priebe W
WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Anticancer research 2001;21(6A):3777-84.
2001: Loetchutinat C; Heywang C; Priebe W; Garnier-Suillerot A
The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.
Biochemical pharmacology 2001;62(5):561-7.
2001: Loetchutinat C; Priebe W; Garnier-Suillerot A
Drug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells.
European journal of biochemistry / FEBS 2001;268(16):4459-67.
2001: Liu H; Hu Y P; Savaraj N; Priebe W; Lampidis T J
Hypersensitization of tumor cells to glycolytic inhibitors.
Biochemistry 2001;40(18):5542-7.
2001: Frézard F; Pereira-Maia E; Quidu P; Priebe W; Garnier-Suillerot A
P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
European journal of biochemistry / FEBS 2001;268(6):1561-7.
2001: Garnier-Suillerot A; Marbeuf-Gueye C; Salerno M; Loetchutinat C; Fokt I; Krawczyk M; Kowalczyk T; Priebe W
Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.
Current medicinal chemistry 2001;8(1):51-64.
2001: Portugal J; Martín B; Vaquero A; Ferrer N; Villamarín S; Priebe W
Analysis of the effects of daunorubicin and WP631 on transcription.
Current medicinal chemistry 2001;8(1):1-8.
2001: Priebe W; Fokt I; Przewloka T; Chaires J B; Portugal J; Trent J O
Exploiting anthracycline scaffold for designing DNA-targeting agents.
Methods in enzymology 2001;340():529-55.
2000: Hu Y; Moraes C T; Savaraj N; Priebe W; Lampidis T J
Rho(0) tumor cells: a model for studying whether mitochondria are targets for rhodamine 123, doxorubicin, and other drugs.
Biochemical pharmacology 2000;60(12):1897-905.
2000: Marbeuf-Gueye C; Priebe W; Garnier-Suillerot A
Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.
Biochemical pharmacology 2000;60(10):1485-9.
2000: Qu X; Trent J O; Fokt I; Priebe W; Chaires J B
Allosteric, chiral-selective drug binding to DNA.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(22):12032-7.
2000: Hooijberg J H; Pinedo H M; Vrasdonk C; Priebe W; Lankelma J; Broxterman H J
The effect of glutathione on the ATPase activity of MRP1 in its natural membranes.
FEBS letters 2000;469(1):47-51.
2000: Booser D J; Perez-Soler R; Cossum P; Esparza-Guerra L; Wu Q P; Zou Y; Priebe W; Hortobagyi G N
Phase I study of liposomal annamycin.
Cancer chemotherapy and pharmacology 2000;46(5):427-32.
2000: Rudnicki W R; Kurzepa M; Szczepanik T; Priebe W; Lesyng B
A simple model for predicting the free energy of binding between anthracycline antibiotics and DNA.
Acta biochimica Polonica 2000;47(1):1-9.
1999: Martín B; Vaquero A; Priebe W; Portugal J
Bisanthracycline WP631 inhibits basal and Sp1-activated transcription initiation in vitro.
Nucleic acids research 1999;27(17):3402-9.
1999: Marbeuf-Gueye C; Ettori D; Priebe W; Kozlowski H; Garnier-Suillerot A
Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.
Biochimica et biophysica acta 1999;1450(3):374-84.
1998: Priebe W; Krawczyk M; Kuo M T; Yamane Y; Savaraj N; Ishikawa T
Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
Biochemical and biophysical research communications 1998;247(3):859-63.
1998: Leng F; Priebe W; Chaires J B
Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.
Biochemistry 1998;37(7):1743-53.
1998: Marbeuf-Gueye C; Broxterman H J; Dubru F; Priebe W; Garnier-Suillerot A
Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Molecular pharmacology 1998;53(1):141-7.
1997: Hu G G; Shui X; Leng F; Priebe W; Chaires J B; Williams L D
Structure of a DNA-bisdaunomycin complex.
Biochemistry 1997;36(20):5940-6.
1997: Perez-Soler R; Neamati N; Zou Y; Schneider E; Doyle L A; Andreeff M; Priebe W; Ling Y H
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
International journal of cancer. Journal international du cancer 1997;71(1):35-41.
1997: Lampidis T J; Kolonias D; Podona T; Israel M; Safa A R; Lothstein L; Savaraj N; Tapiero H; Priebe W
Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge.
Biochemistry 1997;36(9):2679-85.
1997: Chaires J B; Leng F; Przewloka T; Fokt I; Ling Y H; Perez-Soler R; Priebe W
Structure-based design of a new bisintercalating anthracycline antibiotic.
Journal of medicinal chemistry 1997;40(3):261-6.
1996: Gallois L; Fiallo M; Laigle A; Priebe W; Garnier-Suillerot A
The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.
European journal of biochemistry / FEBS 1996;241(3):879-87.
1996: Gao Y G; Priebe W; Wang A H
Substitutions at C2' of daunosamine in the anticancer drug daunorubicin alter its DNA-binding sequence specificity.
European journal of biochemistry / FEBS 1996;240(2):331-5.
1996: Consoli U; Priebe W; Ling Y H; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M
The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines.
Blood 1996;88(2):633-44.
1996: Ling Y H; el-Naggar A K; Priebe W; Perez-Soler R
Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells.
Molecular pharmacology 1996;49(5):832-41.
1996: Jollès B; Laigle A; Priebe W; Garnier-Suillerot A
Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
Chemico-biological interactions 1996;100(2):165-76.
1996: Chaires J B; Satyanarayana S; Suh D; Fokt I; Przewloka T; Priebe W
Parsing the free energy of anthracycline antibiotic binding to DNA.
Biochemistry 1996;35(7):2047-53.
1996: Zou Y; Priebe W; Perez-Soler R
Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size.
Cancer chemotherapy and pharmacology 1996;39(1-2):103-8.
1995: Ishikawa T; Akimaru K; Kuo M T; Priebe W; Suzuki M
How does the MRP/GS-X pump export doxorubicin?
Journal of the National Cancer Institute 1995;87(21):1639-40.
1995: Zou Y; Ling Y H; Reddy S; Priebe W; Perez-Soler R
Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes.
International journal of cancer. Journal international du cancer 1995;61(5):666-71.
1995: Ling Y H; Zou Y; Priebe W; Perez-Soler R
Partial circumvention of multi-drug resistance by annamycin is associated with comparable inhibition of DNA synthesis in the nuclear matrix of sensitive and resistant cells.
International journal of cancer. Journal international du cancer 1995;61(3):402-8.
1994: Borrel M N; Fiallo M; Priebe W; Garnier-Suillerot A
P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
FEBS letters 1994;356(2-3):287-99.
1994: Zhao J Y; Savaraj N; Song R; Priebe W; Kuo M T
Overexpression of P-glycoprotein but not its mRNA in multidrug resistant cells selected with hydroxyrubicin.
Anticancer research 1994;14(5A):1735-42.
1994: Solary E; Ling Y H; Perez-Soler R; Priebe W; Pommier Y
Hydroxyrubicin, a deaminated derivative of doxorubicin, inhibits mammalian DNA topoisomerase II and partially circumvents multidrug resistance.
International journal of cancer. Journal international du cancer 1994;58(1):85-94.
1994: Zou Y; Ling Y H; Van N T; Priebe W; Perez-Soler R
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.
Cancer research 1994;54(6):1479-84.
1994: Perez-Soler R; Ling Y H; Zou Y; Priebe W
Cellular pharmacology of the partially non-cross-resistant anthracycline annamycin entrapped in liposomes in KB and KB-V1 cells.
Cancer chemotherapy and pharmacology 1994;34(2):109-18.
1993: Ling Y H; Priebe W; Perez-Soler R
Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells.
Cancer research 1993;53(8):1845-52.
1993: Ling Y H; Priebe W; Yang L Y; Burke T G; Pommier Y; Perez-Soler R
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes.
Cancer research 1993;53(7):1583-9.
1993: Priebe W; Van N T; Burke T G; Perez-Soler R
Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.
Anti-cancer drugs 1993;4(1):37-48.
1993: Zou Y; Priebe W; Ling Y H; Perez-Soler R
Organ distribution and tumor uptake of annamycin, a new anthracycline derivative with high affinity for lipid membranes, entrapped in multilamellar vesicles.
Cancer chemotherapy and pharmacology 1993;32(3):190-6.
1992: Priebe W; Neamati N; Perez-soler R
3'-Hydroxyesorubicin halogenated at C-2'.
The Journal of antibiotics 1992;45(3):386-93.
1992: Perez-Soler R; Priebe W
Liposomal formulation and antitumor activity of 14-O-palmitoyl-hydroxyrubicin.
Cancer chemotherapy and pharmacology 1992;30(4):267-71.
1990: Priebe W; Neamati N; Perez-Soler R
3'-Hydroxyesorubicin. Synthesis and antitumor activity.
The Journal of antibiotics 1990;43(7):838-46.
1990: Perez-Soler R; Priebe W
Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
Cancer research 1990;50(14):4260-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Waldemar Priebe

Research Profile (preview)

Chemicals & Drugs

Anatomy

Physiology

Living Beings

Genes & Molecular Sequences

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Waldemar Priebe (preview)

All Publications